Antonio V Aragon Ii, MD | |
7411 Wallace Blvd, Amarillo, TX 79106-1835 | |
(806) 351-1870 | |
(806) 355-1284 |
Full Name | Antonio V Aragon Ii |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 29 Years |
Location | 7411 Wallace Blvd, Amarillo, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992774590 | NPI | - | NPPES |
173860101 | Medicaid | TX | |
8G3582 | Other | TX | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | M1474 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Quail Creek Surgical Hospital | Amarillo, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Panhandle Eye Group, Llp | 6204818776 | 23 |
News Archive
The proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients' access to care.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced that it has developed IXS312(VEGF), an antibody fragment with activity against the growth factor VEGF for planned use in ocular treatments.
A major new Series on health and ageing, published in "The Lancet", warns that unless health systems find effective strategies to address the problems faced by an ageing world population, the growing burden of chronic disease will greatly affect the quality of life of older people. As people across the world live longer, soaring levels of chronic illness and diminished wellbeing are poised to become a major global public health challenge.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
› Verified 3 days ago
Entity Name | Panhandle Eye Group, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760571723 PECOS PAC ID: 6204818776 Enrollment ID: O20040607001217 |
News Archive
The proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients' access to care.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced that it has developed IXS312(VEGF), an antibody fragment with activity against the growth factor VEGF for planned use in ocular treatments.
A major new Series on health and ageing, published in "The Lancet", warns that unless health systems find effective strategies to address the problems faced by an ageing world population, the growing burden of chronic disease will greatly affect the quality of life of older people. As people across the world live longer, soaring levels of chronic illness and diminished wellbeing are poised to become a major global public health challenge.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Antonio V Aragon Ii, MD Po Box 50720, Amarillo, TX 79159-0720 Ph: (806) 467-0459 | Antonio V Aragon Ii, MD 7411 Wallace Blvd, Amarillo, TX 79106-1835 Ph: (806) 351-1870 |
News Archive
The proposed merger of a well-regarded secular hospital system and a larger Roman Catholic system in Washington state has triggered new alarms about religious restrictions on patients' access to care.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced that it has developed IXS312(VEGF), an antibody fragment with activity against the growth factor VEGF for planned use in ocular treatments.
A major new Series on health and ageing, published in "The Lancet", warns that unless health systems find effective strategies to address the problems faced by an ageing world population, the growing burden of chronic disease will greatly affect the quality of life of older people. As people across the world live longer, soaring levels of chronic illness and diminished wellbeing are poised to become a major global public health challenge.
Pharmacyclics, Inc. today announced results from a Phase I study of its novel orally administered Bruton's tyrosine kinase (Btk) inhibitor, PCI-32765, in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (NHL) including chronic lymphocytic leukemia (CLL) and Waldenstroms Macroglobulinemia (WM). These data are being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago, IL.
› Verified 3 days ago
Robert E Gerald, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7625 Fleming Ave, Amarillo, TX 79106 Phone: 806-353-0125 Fax: 806-355-0834 | |
Amber A Dobler-dixon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-350-1100 Fax: 806-350-1101 | |
Bruce L Weinberger, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 700 Quail Creek Dr, Amarillo, TX 79124 Phone: 806-353-6691 Fax: 806-355-1284 | |
Christopher Alan Mccarty, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-351-1177 Fax: 806-355-1284 | |
Jason Edward Ysasaga, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-351-1870 Fax: 806-355-1284 | |
Dr. Sloan Whitmore Rush, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7625 Fleming Ave, Amarillo, TX 79106 Phone: 806-353-0125 Fax: 806-355-0834 | |
Jennifer Rene Gallagher, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7411 Wallace Blvd, Amarillo, TX 79106 Phone: 806-351-1870 |